Navigation Links
New Study on Cordyceps Sinensis (Hirsutella Sinensis) Shows Anti-Inflammatory Properties
Date:4/30/2013

Los Angeles, CA (PRWEB) April 30, 2013

Cordyceps sinensis is a medicinal fungus used for centuries in Asian countries as a health supplement and tonic. Traditionally prescribed by medical practitioners as a kidney and lung supplement, studies have found Cordyceps Sinensis’ impact on the human body reaches other functions as well, such as energy, fertility and anti-inflammation.*

Published in the March 5, 2013 issue of Scientific Journal, a new study details findings revealing Cordyceps Sinensis’ anti-inflammatory properties. These benefits were attributed to Cordyceps Sinensis’ ability to inhibit both canonical and non-canonical inflammasomes. Inflammasomes have been associated with several auto-inflammatory conditions such as gout. This study, performed at the Center for Molecular and Clinical Immunology at Chang Gung University in Taiwan, documents Cordyceps Sinensis’ suppression of interleukin-1ß and interleukin-18 secretion.

The study uses a specific anamorphic mycelial form of Cordyceps Sinensis known as Hirsutella Sinensis. This specific strain has proven to be rare and difficult to cultivate. Through Molecular Germplasm Identification, this particular strain of Cordyceps Sinensis' rDNA sequence matches wild-grown Cordyceps Sinensis by 99.645%, proving authenticity. Other strains on the market match only by 82.791%.

Download Cordyceps Sinensis (Hirsutella Sinensis) Clinical Trial

How to cite the study: Huang, T. et al. Hirsutella sinensis mycelium suppresses interleukin-1b and interleukin-18 secretion by inhibiting both canonical and non-canonical inflammasomes. Sci. Rep. 3, 1374; DOI:10.1038/srep01374 (2013).

*Legal Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

Read the full story at http://www.prweb.com/releases/cordyceps-sinensis/hirstuella-sinensis/prweb10684567.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. New Study: Valtrex (Valacyclovir) Side Effects Target the Brain; polyDNA Suggests a Natural Herpes Remedy
2. Wysebridge Patent Bar Review Launches America Invents Act (AIA) Study Suite
3. Breath study brings roadside drug testing closer
4. Japan Bioinformatics Announces Release of a Case Study on Detecting SNPs and Short INDELs
5. Research Foundations Collaborate To Fund Phase 1 Study Of Cancer Drug In Alzheimers Disease Patients
6. Ceregene Reports Data From Parkinsons Disease Phase 2b Study
7. Study Says Kidney Bean Leaves Work Against Bed Bugs, My Cleaning Products Compares Its With a Non-Pesticide Bed Bug Spray
8. NeuroDerm Announces Enrollment in a Phase 2 Study of ND0612, a Continuous Levodopa/Carbidopa Drug for the Treatment of Parkinsons Disease
9. A bright idea: Tiny injectable LEDs help neuroscientists study the brain
10. Study Says Bed Bugs Show Resistance to Pesticides, My Cleaning Products Asserts Non-Pesticide Bed Bug Bully Is the Better Pick Against the Pests
11. Inflamax Research Chosen to Conduct a Multicenter Environmental Exposure Chamber Phase 3 Study of Ultrashort Grass Allergy Vaccine by Allergy Therapeutics (UK) Ltd.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/9/2016)... ... February 09, 2016 , ... Clinovo , the cloud-based ... Electronic Data Capture (EDC) system ClinCaptureand its new Contract Research Organization (CRO) Partner ... Conference in San Mateo, California on February 10th and 11th. Watch 2-min ...
(Date:2/9/2016)... ... February 09, 2016 , ... PharmApprove ... for the National Organization for Rare Disorders (NORD). Dorman will lead PharmApprove efforts ... are heard throughout the drug regulatory review process. , “Adding Diane Dorman is ...
(Date:2/9/2016)... February 9, 2016 Three-Year Initiative Supports ... to Take Part in Life-Changing Camp ... designed to positively affect the lives of children born with rare ... --> SHPG ) is announcing a new initiative designed to ... well as the future of rare disease care. --> ...
(Date:2/8/2016)... Pa. , Feb. 8, 2016 Should ... standard bone cement products to prevent infection after standard ... that the experts at ECRI Institute have been fielding ... Infection or Fighting Your Bottom Line?" ... Your Bottom Line?" --> While ...
Breaking Biology Technology:
(Date:2/2/2016)... 2016 Checkpoint Inhibitors for Cancer – ... Are you interested in the future of cancer ... inhibitors. Visiongain,s report gives those predictions to 2026 ... level. Avoid falling behind in data or ... revenues those emerging cancer therapies can achieve. There ...
(Date:2/2/2016)... RESTON, Va. , Feb. 2, 2016 /PRNewswire/ ... contract award from the U.S. Army Research Office ... extend the range and sensitivity of the company,s ... DoD,s Past Accounting Mission and, more generally, defense-related ... its DNA phenotyping capabilities (predicting appearance and ancestry ...
(Date:2/1/2016)... 2016 Rising sales of consumer ... touchfree intuitive gesture control market size ... of consumer electronics coupled with new technological advancements to ... size through 2020   --> ... technological advancements to drive global touchfree intuitive gesture control ...
Breaking Biology News(10 mins):